Siegfried recently invested in expanding its drug product development network, by recently opening a Development Center for Oral solid formluations and Ophthalmics in the Barcelona, Spain area. The Siegfried Development network currently employs 50 experts in developing OSD incl. high potency, sterile injectable and Ophthalmic formulations. Along with the existing network of clinical and high scale commercial manufacturing, Siegfried has now the competence and capabilities to collaborate together with you from development, through GMP clinical to commercial high scale stage.